Related Subjects:
|Acute Stroke Assessment (ROSIER&NIHSS)
|Atrial Fibrillation
|Atrial Myxoma
|Causes of Stroke
|Ischaemic Stroke
|Cancer and Stroke
|Cardioembolic stroke
|CT Basics for Stroke
|Endocarditis and Stroke
|Haemorrhagic Stroke
|Stroke Thrombolysis
|Hyperacute Stroke Care
Cardioembolic stroke = cerebral ischaemia from emboli arising in the 💓 heart (atria, ventricles, valves) that travel to cerebral arteries.
🔄 Also includes paradoxical emboli via PFO/ASD.
📊 They account for 15–30% of all ischaemic strokes, with mortality up to 30%.
⚡ In those >80y, >20% of strokes are AF-related → major prevention opportunity with anticoagulation.
💥 Causes & Sources
- High Risk Sources:
- 🫀 Atrial fibrillation (AF): Valvular & non-valvular; risk stratified by CHA2DS2-VASc.
- ❤️ Recent MI: esp. LV aneurysm/hypokinesia.
- ⚙️ Mechanical valves: very thrombogenic.
- 🫁 Dilated cardiomyopathy: chamber stasis → thrombus.
- 🫀 Rheumatic mitral stenosis: atrial enlargement + stasis.
- Other Sources:
- 🦠 Infective endocarditis: septic vegetations embolise.
- 🎗 Atrial myxoma: fragments embolise.
- 🔄 PFO: paradoxical embolus from venous system.
- 💓 LAA thrombus: classic in AF.
- 🪨 Mitral prolapse/calcification: thrombogenic.
- 🧬 Marantic endocarditis: malignancy, SLE.
📚 Classification
- 🏛 Cardiac wall/chamber: cardiomyopathies, LV aneurysm, atrial septal aneurysm, myxoma, fibroelastomas, thrombi, septal defects (PFO/ASD).
- 🫀 Valvular disease: RHD, prosthetic valves, infective or Libman–Sacks endocarditis, MVP, annular calcification.
- ⚡ Arrhythmias: AF, flutter, sick sinus syndrome.
🩺 Clinical Features
- ⚡ Sudden onset, deficits maximal at onset.
- 🌍 Multiple territories can be affected.
- ↕️ Fluctuating symptoms if embolus fragments.
- 🛑 Large vessel occlusion: MCA, ICA, PCA.
- 🩸 High risk of haemorrhagic transformation.
- 🧑⚕️ May present with ↓ consciousness, seizures at onset.
🔑 Look for cardiac signs: irregular pulse (AF), murmurs, heart failure, IE stigmata.
📊 Causes & Frequency
- AF (non-valvular): ~50% → stroke risk ↑3–5x.
- Recent MI: ~10% → esp. anterior MI, early weeks.
- LV thrombus: ~10% → echo for detection.
- Rheumatic MS: ~10% → very high embolic risk.
- Mechanical valves: ~5% → lifelong warfarin.
- Other (tumours, IE, PFO): ~15%.
🏗 Structural Heart Disease
- 💔 Cardiomyopathy (dilated, hypertrophic, restrictive).
- 🦠 Infective endocarditis.
- 🎗 Atrial myxoma (constitutional + embolic signs).
- 🩸 LV aneurysm post-MI.
- 🪨 Mitral valve prolapse/calcification.
- 🔄 PFO in cryptogenic stroke (younger pts).
🧪 Investigations
- 🩸 Bloods: FBC, coagulation, ESR, cultures (if IE suspected).
- 📉 ECG: AF, MI changes.
- 📡 Holter: detect paroxysmal AF.
- 🖼 CT/MRI brain: multiple embolic infarcts, DWI sensitive.
- 🧲 CTA/MRA: vessel occlusions.
- 🫀 Echo:
- TTE: chamber size, LV function.
- TEE: LAA thrombus, vegetations, PFO (with bubble study).
- 🧠 TCD: detect microemboli, shunts.
⚕️ Management
- 🚨 Acute stroke protocols: reperfusion therapy (IVT/thrombectomy) as per guidelines.
- 💊 Anticoagulation:
- DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) for non-valvular AF.
- Warfarin for mechanical valves & rheumatic MS (DOACs not licensed).
- Timing: start 4–14d post-stroke depending on size/bleed risk.
- ❤️ Underlying cardiac care: heart failure optimisation, valve surgery, tumour excision if relevant.
- 🛡 Risk factor control: BP, DM, statins, smoking cessation.
- 🤝 Team approach: neuro + cardiology + stroke rehab.
📈 Prognosis
- ⬆️ More severe strokes (large artery occlusion).
- ⚰️ Higher early mortality vs other stroke subtypes.
- 🔄 High recurrence risk if no anticoagulation.
- 🦽 Often require prolonged rehab; less likely to be fully independent.
📚 References
- Hart RG, Diener HC, Coutts SB. Embolic strokes of undetermined source. Lancet Neurol. 2014.
- Adams HP Jr et al. TOAST classification of stroke subtypes. Stroke. 1993.
- January CT et al. 2019 AHA/ACC/HRS AF management update. Circulation. 2019.
- AHA/ASA. Guidelines for early management of acute ischaemic stroke. Stroke. 2019.
- Arboix A, Alió J. Cardioembolic Stroke. Curr Cardiol Rev. 2010.